Clinical Trial Update: A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and effects of Salanersen (BIIB115) in babies with spinal muscular atrophy who were previously treated with Onasemn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• Salanersen (BIIB115)

Snippet

Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Phase 3 | Status: NOT_YET_RECRUITING